> top > docs > PubMed:21130517 > annotations

PubMed:21130517 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
8388 13-17 GeneOrGeneProduct denotes EGFR NCBIGene:1956
8389 47-58 DiseaseOrPhenotypicFeature denotes lung cancer MESH:D008175
8390 59-67 OrganismTaxon denotes patients NCBITaxon:9606
8391 117-122 DiseaseOrPhenotypicFeature denotes tumor MESH:D009369
8392 123-127 GeneOrGeneProduct denotes EGFR NCBIGene:1956
8393 151-155 GeneOrGeneProduct denotes EGFR NCBIGene:1956
8394 174-178 GeneOrGeneProduct denotes EGFR NCBIGene:1956
8395 219-223 GeneOrGeneProduct denotes EGFR NCBIGene:1956
8396 244-255 DiseaseOrPhenotypicFeature denotes lung cancer MESH:D008175
8397 275-279 GeneOrGeneProduct denotes EGFR NCBIGene:1956
8398 327-332 DiseaseOrPhenotypicFeature denotes tumor MESH:D009369
8399 512-516 GeneOrGeneProduct denotes EGFR NCBIGene:1956
8400 551-559 OrganismTaxon denotes patients NCBITaxon:9606
8401 565-576 DiseaseOrPhenotypicFeature denotes lung cancer MESH:D008175
8402 637-645 OrganismTaxon denotes patients NCBITaxon:9606
8403 679-683 GeneOrGeneProduct denotes EGFR NCBIGene:1956
8404 705-709 GeneOrGeneProduct denotes EGFR NCBIGene:1956
8405 710-715 SequenceVariant denotes L858R DBSNP:rs121434568
8406 775-779 GeneOrGeneProduct denotes EGFR NCBIGene:1956
8407 808-813 DiseaseOrPhenotypicFeature denotes tumor MESH:D009369
8408 825-829 GeneOrGeneProduct denotes EGFR NCBIGene:1956
8409 859-863 GeneOrGeneProduct denotes EGFR NCBIGene:1956
8410 883-888 DiseaseOrPhenotypicFeature denotes tumor MESH:D009369
8411 958-962 GeneOrGeneProduct denotes EGFR NCBIGene:1956
8412 1022-1027 DiseaseOrPhenotypicFeature denotes tumor MESH:D009369
8413 1038-1046 OrganismTaxon denotes patients NCBITaxon:9606
8414 1151-1155 GeneOrGeneProduct denotes EGFR NCBIGene:1956
8415 1182-1186 GeneOrGeneProduct denotes EGFR NCBIGene:1956
8416 1187-1192 SequenceVariant denotes L858R DBSNP:rs121434568
8417 1239-1245 DiseaseOrPhenotypicFeature denotes tumors MESH:D009369
8418 1311-1316 DiseaseOrPhenotypicFeature denotes tumor MESH:D009369
8419 1381-1389 OrganismTaxon denotes patients NCBITaxon:9606
8420 1403-1412 ChemicalEntity denotes erlotinib MESH:D000069347
8421 1467-1471 GeneOrGeneProduct denotes EGFR NCBIGene:1956
8422 1498-1503 DiseaseOrPhenotypicFeature denotes tumor MESH:D009369
8423 1535-1543 OrganismTaxon denotes patients NCBITaxon:9606
8424 1643-1647 GeneOrGeneProduct denotes EGFR NCBIGene:1956
8425 1747-1751 GeneOrGeneProduct denotes EGFR NCBIGene:1956
8426 1805-1810 DiseaseOrPhenotypicFeature denotes tumor MESH:D009369
8427 1811-1815 GeneOrGeneProduct denotes EGFR NCBIGene:1956
8428 1860-1864 GeneOrGeneProduct denotes EGFR NCBIGene:1956
8429 1945-1953 OrganismTaxon denotes patients NCBITaxon:9606
8430 1987-1992 DiseaseOrPhenotypicFeature denotes tumor MESH:D009369

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T1 0-167 Sentence denotes Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors.
T2 168-256 Sentence denotes AIMS: EGFR mutations now guide the clinical use of EGFR-targeted therapy in lung cancer.
T3 257-390 Sentence denotes However, standard EGFR mutation analysis requires a minimum amount of tumor tissue, which may not be available in certain situations.
T4 391-577 Sentence denotes In this study, we combined a mass spectrometry genotyping assay (Sequenom) with a mutant-enriched PCR (ME-PCR) to detect EGFR mutations in free plasma DNA from patients with lung cancer.
T5 578-725 Sentence denotes METHOD: DNAs were extracted from 31 plasma samples from 31 patients and analyzed by both methods for EGFR Exon 19 deletion and EGFR L858R mutation.
T6 726-838 Sentence denotes Results in plasma DNA samples were compared with EGFR mutation status obtained in tumor DNA (18/31 EGFR mutant).
T7 839-944 Sentence denotes The relationship of EGFR mutation status in tumor and/or plasma samples to overall survival was assessed.
T8 945-953 Sentence denotes RESULTS:
T9 954-1055 Sentence denotes The EGFR mutation status in plasma DNA was identical to the primary tumor in 61% of patients (19/31).
T10 1056-1246 Sentence denotes By mass spectrometry genotyping, the plasma samples contained mutant DNA corresponding to 5/14 EGFR Exon 19 deletions and 3/4 EGFR L858R mutations previously diagnosed in the matched tumors.
T11 1247-1324 Sentence denotes Two samples were positive in plasma DNA but negative in primary tumor tissue.
T12 1325-1376 Sentence denotes Results were similar for samples studied by ME-PCR.
T13 1377-1613 Sentence denotes For patients treated with erlotinib, overall survival was correlated with the presence of EGFR mutation in plasma and/or tumor tissue (p=0.002), with the two patients positive only in plasma DNA showing responses and favorable outcomes.
T14 1614-1625 Sentence denotes CONCLUSION:
T15 1626-1735 Sentence denotes The detection of EGFR mutations in plasma DNA samples by mass spectrometry genotyping and ME-PCR is feasible.
T16 1736-2003 Sentence denotes A positive EGFR result in plasma DNA has a high predictive value for tumor EGFR status and for favorable clinical course on EGFR-targeted therapy and could therefore be useful in guiding clinical decisions in patients with insufficient or unavailable tumor specimens.

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 47-58 DiseaseOrPhenotypicFeature denotes lung cancer 0008903
T2 52-58 DiseaseOrPhenotypicFeature denotes cancer 0004992
T3 244-255 DiseaseOrPhenotypicFeature denotes lung cancer 0008903
T4 249-255 DiseaseOrPhenotypicFeature denotes cancer 0004992
T5 565-576 DiseaseOrPhenotypicFeature denotes lung cancer 0008903
T6 570-576 DiseaseOrPhenotypicFeature denotes cancer 0004992

LitCoin-SeqVar

Id Subject Object Predicate Lexical cue
T1 710-715 SequenceVariant denotes L858R
T2 1187-1192 SequenceVariant denotes L858R

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T52 1472-1480 GeneOrGeneProduct denotes mutation
T53 1495-1503 GeneOrGeneProduct denotes or tumor
T54 1643-1647 GeneOrGeneProduct denotes EGFR
T55 1648-1657 GeneOrGeneProduct denotes mutations
T56 1683-1687 GeneOrGeneProduct denotes mass
T57 1716-1718 GeneOrGeneProduct denotes ME
T58 1747-1751 GeneOrGeneProduct denotes EGFR
T59 1773-1778 GeneOrGeneProduct denotes has a
T60 1779-1783 GeneOrGeneProduct denotes high
T61 1784-1794 GeneOrGeneProduct denotes predictive
T62 1795-1800 GeneOrGeneProduct denotes value
T63 1805-1810 GeneOrGeneProduct denotes tumor
T64 1811-1815 GeneOrGeneProduct denotes EGFR
T65 1860-1864 GeneOrGeneProduct denotes EGFR
T66 1987-1992 GeneOrGeneProduct denotes tumor
T4 71-75 GeneOrGeneProduct denotes mass
T1 13-17 GeneOrGeneProduct denotes EGFR
T2 18-27 GeneOrGeneProduct denotes mutations
T3 47-51 GeneOrGeneProduct denotes lung
T5 103-113 GeneOrGeneProduct denotes predictive
T6 114-122 GeneOrGeneProduct denotes of tumor
T7 123-127 GeneOrGeneProduct denotes EGFR
T8 151-155 GeneOrGeneProduct denotes EGFR
T9 156-166 GeneOrGeneProduct denotes inhibitors
T10 174-178 GeneOrGeneProduct denotes EGFR
T11 179-188 GeneOrGeneProduct denotes mutations
T12 219-223 GeneOrGeneProduct denotes EGFR
T13 244-248 GeneOrGeneProduct denotes lung
T14 275-279 GeneOrGeneProduct denotes EGFR
T15 280-288 GeneOrGeneProduct denotes mutation
T16 324-332 GeneOrGeneProduct denotes of tumor
T17 351-367 GeneOrGeneProduct denotes not be available
T18 420-424 GeneOrGeneProduct denotes mass
T19 473-479 GeneOrGeneProduct denotes mutant
T20 494-496 GeneOrGeneProduct denotes ME
T21 512-516 GeneOrGeneProduct denotes EGFR
T22 517-526 GeneOrGeneProduct denotes mutations
T23 565-569 GeneOrGeneProduct denotes lung
T24 578-584 GeneOrGeneProduct denotes METHOD
T25 586-590 GeneOrGeneProduct denotes DNAs
T26 667-674 GeneOrGeneProduct denotes methods
T27 679-683 GeneOrGeneProduct denotes EGFR
T28 705-709 GeneOrGeneProduct denotes EGFR
T29 716-724 GeneOrGeneProduct denotes mutation
T45 1182-1186 GeneOrGeneProduct denotes EGFR
T30 775-779 GeneOrGeneProduct denotes EGFR
T46 1193-1202 GeneOrGeneProduct denotes mutations
T31 780-788 GeneOrGeneProduct denotes mutation
T47 1239-1245 GeneOrGeneProduct denotes tumors
T48 1311-1316 GeneOrGeneProduct denotes tumor
T32 808-813 GeneOrGeneProduct denotes tumor
T33 825-829 GeneOrGeneProduct denotes EGFR
T49 1338-1345 GeneOrGeneProduct denotes similar
T50 1369-1371 GeneOrGeneProduct denotes ME
T34 830-836 GeneOrGeneProduct denotes mutant
T35 859-863 GeneOrGeneProduct denotes EGFR
T36 864-872 GeneOrGeneProduct denotes mutation
T51 1467-1471 GeneOrGeneProduct denotes EGFR
T37 883-888 GeneOrGeneProduct denotes tumor
T38 958-962 GeneOrGeneProduct denotes EGFR
T39 963-971 GeneOrGeneProduct denotes mutation
T40 1022-1027 GeneOrGeneProduct denotes tumor
T41 1059-1063 GeneOrGeneProduct denotes mass
T42 1118-1124 GeneOrGeneProduct denotes mutant
T43 1151-1155 GeneOrGeneProduct denotes EGFR
T44 1174-1181 GeneOrGeneProduct denotes and 3/4

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 13-17 GeneOrGeneProduct denotes EGFR
T2 123-127 GeneOrGeneProduct denotes EGFR
T3 151-155 GeneOrGeneProduct denotes EGFR
T4 156-166 GeneOrGeneProduct denotes inhibitors
T5 174-178 GeneOrGeneProduct denotes EGFR
T6 219-223 GeneOrGeneProduct denotes EGFR
T7 275-279 GeneOrGeneProduct denotes EGFR
T8 351-367 GeneOrGeneProduct denotes not be available
T9 473-479 GeneOrGeneProduct denotes mutant
T10 512-516 GeneOrGeneProduct denotes EGFR
T11 679-683 GeneOrGeneProduct denotes EGFR
T12 705-709 GeneOrGeneProduct denotes EGFR
T13 775-779 GeneOrGeneProduct denotes EGFR
T14 825-829 GeneOrGeneProduct denotes EGFR
T15 830-836 GeneOrGeneProduct denotes mutant
T16 859-863 GeneOrGeneProduct denotes EGFR
T17 958-962 GeneOrGeneProduct denotes EGFR
T18 1118-1124 GeneOrGeneProduct denotes mutant
T19 1151-1155 GeneOrGeneProduct denotes EGFR
T20 1174-1181 GeneOrGeneProduct denotes and 3/4
T21 1182-1186 GeneOrGeneProduct denotes EGFR
T22 1338-1345 GeneOrGeneProduct denotes similar
T23 1467-1471 GeneOrGeneProduct denotes EGFR
T24 1643-1647 GeneOrGeneProduct denotes EGFR
T25 1747-1751 GeneOrGeneProduct denotes EGFR
T26 1779-1783 GeneOrGeneProduct denotes high
T27 1811-1815 GeneOrGeneProduct denotes EGFR
T28 1860-1864 GeneOrGeneProduct denotes EGFR

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 47-58 DiseaseOrPhenotypicFeature denotes lung cancer D008175
T2 117-122 DiseaseOrPhenotypicFeature denotes tumor D009369
T3 244-255 DiseaseOrPhenotypicFeature denotes lung cancer D008175
T4 327-332 DiseaseOrPhenotypicFeature denotes tumor D009369
T5 565-576 DiseaseOrPhenotypicFeature denotes lung cancer D008175
T6 808-813 DiseaseOrPhenotypicFeature denotes tumor D009369
T7 883-888 DiseaseOrPhenotypicFeature denotes tumor D009369
T8 1022-1027 DiseaseOrPhenotypicFeature denotes tumor D009369
T9 1239-1245 DiseaseOrPhenotypicFeature denotes tumors D009369
T10 1311-1316 DiseaseOrPhenotypicFeature denotes tumor D009369
T11 1498-1503 DiseaseOrPhenotypicFeature denotes tumor D009369
T12 1805-1810 DiseaseOrPhenotypicFeature denotes tumor D009369
T13 1987-1992 DiseaseOrPhenotypicFeature denotes tumor D009369

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T1 13-17 GeneOrGeneProduct denotes EGFR
T2 123-127 GeneOrGeneProduct denotes EGFR
T3 151-155 GeneOrGeneProduct denotes EGFR
T4 174-178 GeneOrGeneProduct denotes EGFR
T5 219-223 GeneOrGeneProduct denotes EGFR
T6 275-279 GeneOrGeneProduct denotes EGFR
T7 351-367 GeneOrGeneProduct denotes not be available
T8 512-516 GeneOrGeneProduct denotes EGFR
T9 679-683 GeneOrGeneProduct denotes EGFR
T10 705-709 GeneOrGeneProduct denotes EGFR
T11 775-779 GeneOrGeneProduct denotes EGFR
T12 825-829 GeneOrGeneProduct denotes EGFR
T13 859-863 GeneOrGeneProduct denotes EGFR
T14 958-962 GeneOrGeneProduct denotes EGFR
T15 1151-1155 GeneOrGeneProduct denotes EGFR
T16 1174-1181 GeneOrGeneProduct denotes and 3/4
T17 1182-1186 GeneOrGeneProduct denotes EGFR
T18 1467-1471 GeneOrGeneProduct denotes EGFR
T19 1643-1647 GeneOrGeneProduct denotes EGFR
T20 1747-1751 GeneOrGeneProduct denotes EGFR
T21 1811-1815 GeneOrGeneProduct denotes EGFR
T22 1860-1864 GeneOrGeneProduct denotes EGFR

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 47-58 DiseaseOrPhenotypicFeature denotes lung cancer 0008903|0005138
T3 117-122 DiseaseOrPhenotypicFeature denotes tumor 0005070
T4 244-255 DiseaseOrPhenotypicFeature denotes lung cancer 0008903|0005138
T6 327-332 DiseaseOrPhenotypicFeature denotes tumor 0005070
T7 565-576 DiseaseOrPhenotypicFeature denotes lung cancer 0008903|0005138
T9 808-813 DiseaseOrPhenotypicFeature denotes tumor 0005070
T10 883-888 DiseaseOrPhenotypicFeature denotes tumor 0005070
T11 1022-1027 DiseaseOrPhenotypicFeature denotes tumor 0005070
T12 1311-1316 DiseaseOrPhenotypicFeature denotes tumor 0005070
T13 1498-1503 DiseaseOrPhenotypicFeature denotes tumor 0005070
T14 1805-1810 DiseaseOrPhenotypicFeature denotes tumor 0005070
T15 1987-1992 DiseaseOrPhenotypicFeature denotes tumor 0005070

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 47-58 DiseaseOrPhenotypicFeature denotes lung cancer D008175
T2 117-122 DiseaseOrPhenotypicFeature denotes tumor D009369
T3 244-255 DiseaseOrPhenotypicFeature denotes lung cancer D008175
T4 327-332 DiseaseOrPhenotypicFeature denotes tumor D009369
T5 565-576 DiseaseOrPhenotypicFeature denotes lung cancer D008175
T6 808-813 DiseaseOrPhenotypicFeature denotes tumor D009369
T7 883-888 DiseaseOrPhenotypicFeature denotes tumor D009369
T8 1022-1027 DiseaseOrPhenotypicFeature denotes tumor D009369
T9 1239-1245 DiseaseOrPhenotypicFeature denotes tumors DISEASE|D009369
T11 1311-1316 DiseaseOrPhenotypicFeature denotes tumor D009369
T12 1498-1503 DiseaseOrPhenotypicFeature denotes tumor D009369
T13 1805-1810 DiseaseOrPhenotypicFeature denotes tumor D009369
T14 1987-1992 DiseaseOrPhenotypicFeature denotes tumor D009369

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 47-58 DiseaseOrPhenotypicFeature denotes lung cancer D008175
T2 117-122 DiseaseOrPhenotypicFeature denotes tumor D009369
T3 244-255 DiseaseOrPhenotypicFeature denotes lung cancer D008175
T4 327-332 DiseaseOrPhenotypicFeature denotes tumor D009369
T5 565-576 DiseaseOrPhenotypicFeature denotes lung cancer D008175
T6 808-813 DiseaseOrPhenotypicFeature denotes tumor D009369
T7 883-888 DiseaseOrPhenotypicFeature denotes tumor D009369
T8 1022-1027 DiseaseOrPhenotypicFeature denotes tumor D009369
T9 1239-1245 DiseaseOrPhenotypicFeature denotes tumors D009369
T10 1311-1316 DiseaseOrPhenotypicFeature denotes tumor D009369
T11 1498-1503 DiseaseOrPhenotypicFeature denotes tumor D009369
T12 1805-1810 DiseaseOrPhenotypicFeature denotes tumor D009369
T13 1987-1992 DiseaseOrPhenotypicFeature denotes tumor D009369

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 59-67 OrganismTaxon denotes patients
T2 551-559 OrganismTaxon denotes patients
T3 637-645 OrganismTaxon denotes patients
T4 1038-1046 OrganismTaxon denotes patients
T5 1381-1389 OrganismTaxon denotes patients
T6 1535-1543 OrganismTaxon denotes patients
T7 1945-1953 OrganismTaxon denotes patients

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 1403-1412 ChemicalEntity denotes erlotinib D000069347|http://purl.obolibrary.org/obo/CHEBI_114785

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T1 1403-1412 ChemicalEntity denotes erlotinib http://purl.obolibrary.org/obo/CHEBI_114785|D000069347
T22 1860-1864 GeneOrGeneProduct denotes EGFR
T21 1811-1815 GeneOrGeneProduct denotes EGFR
T20 1747-1751 GeneOrGeneProduct denotes EGFR
T19 1643-1647 GeneOrGeneProduct denotes EGFR
T18 1467-1471 GeneOrGeneProduct denotes EGFR
T17 1182-1186 GeneOrGeneProduct denotes EGFR
T16 1174-1181 GeneOrGeneProduct denotes and 3/4
T15 1151-1155 GeneOrGeneProduct denotes EGFR
T14 958-962 GeneOrGeneProduct denotes EGFR
T13 859-863 GeneOrGeneProduct denotes EGFR
T12 825-829 GeneOrGeneProduct denotes EGFR
T11 775-779 GeneOrGeneProduct denotes EGFR
T10 705-709 GeneOrGeneProduct denotes EGFR
T9 679-683 GeneOrGeneProduct denotes EGFR
T8 512-516 GeneOrGeneProduct denotes EGFR
T7 351-367 GeneOrGeneProduct denotes not be available
T6 275-279 GeneOrGeneProduct denotes EGFR
T5 219-223 GeneOrGeneProduct denotes EGFR
T4 174-178 GeneOrGeneProduct denotes EGFR
T3 151-155 GeneOrGeneProduct denotes EGFR
T2 123-127 GeneOrGeneProduct denotes EGFR
T70413 13-17 GeneOrGeneProduct denotes EGFR
T46292 1987-1992 DiseaseOrPhenotypicFeature denotes tumor D009369
T69961 1805-1810 DiseaseOrPhenotypicFeature denotes tumor D009369
T94511 1498-1503 DiseaseOrPhenotypicFeature denotes tumor D009369
T81106 1311-1316 DiseaseOrPhenotypicFeature denotes tumor D009369
T36433 1239-1245 DiseaseOrPhenotypicFeature denotes tumors D009369
T47749 1022-1027 DiseaseOrPhenotypicFeature denotes tumor D009369
T82308 883-888 DiseaseOrPhenotypicFeature denotes tumor D009369
T25355 808-813 DiseaseOrPhenotypicFeature denotes tumor D009369
T55976 565-576 DiseaseOrPhenotypicFeature denotes lung cancer D008175
T65328 327-332 DiseaseOrPhenotypicFeature denotes tumor D009369
T36522 244-255 DiseaseOrPhenotypicFeature denotes lung cancer D008175
T51452 117-122 DiseaseOrPhenotypicFeature denotes tumor D009369
T80502 47-58 DiseaseOrPhenotypicFeature denotes lung cancer D008175
T24194 1945-1953 OrganismTaxon denotes patients
T61362 1535-1543 OrganismTaxon denotes patients
T94746 1381-1389 OrganismTaxon denotes patients
T58730 1038-1046 OrganismTaxon denotes patients
T97441 637-645 OrganismTaxon denotes patients
T9055 551-559 OrganismTaxon denotes patients
T45204 59-67 OrganismTaxon denotes patients
T74891 1187-1192 SequenceVariant denotes L858R
T24659 710-715 SequenceVariant denotes L858R

DisGeNET

Id Subject Object Predicate Lexical cue
T0 219-223 gene:1956 denotes EGFR
T1 244-255 disease:C0684249 denotes lung cancer
T2 219-223 gene:1956 denotes EGFR
T3 244-255 disease:C0242379 denotes lung cancer
T4 174-178 gene:1956 denotes EGFR
T5 244-255 disease:C0242379 denotes lung cancer
T6 174-178 gene:1956 denotes EGFR
T7 244-255 disease:C0684249 denotes lung cancer
T8 512-516 gene:1956 denotes EGFR
T9 565-576 disease:C0684249 denotes lung cancer
T10 512-516 gene:1956 denotes EGFR
T11 565-576 disease:C0242379 denotes lung cancer
R1 T0 T1 associated_with EGFR,lung cancer
R2 T2 T3 associated_with EGFR,lung cancer
R3 T4 T5 associated_with EGFR,lung cancer
R4 T6 T7 associated_with EGFR,lung cancer
R5 T8 T9 associated_with EGFR,lung cancer
R6 T10 T11 associated_with EGFR,lung cancer

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 244-255 HP_0100526 denotes lung cancer
T2 249-255 HP_0002664 denotes cancer
T3 327-332 HP_0002664 denotes tumor
T4 565-576 HP_0100526 denotes lung cancer
T5 570-576 HP_0002664 denotes cancer

Allie

Id Subject Object Predicate Lexical cue
SS1_21130517_4_0 473-492 expanded denotes mutant-enriched PCR
SS2_21130517_4_0 494-500 abbr denotes ME-PCR
AE1_21130517_4_0 SS1_21130517_4_0 SS2_21130517_4_0 abbreviatedTo mutant-enriched PCR,ME-PCR

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
21130517-0#13#17#gene1956 13-17 gene1956 denotes EGFR
21130517-0#47#58#diseaseC0242379 47-58 diseaseC0242379 denotes lung cancer
21130517-0#47#58#diseaseC0684249 47-58 diseaseC0684249 denotes lung cancer
21130517-0#47#58#diseaseC1306460 47-58 diseaseC1306460 denotes lung cancer
13#17#gene195647#58#diseaseC0242379 21130517-0#13#17#gene1956 21130517-0#47#58#diseaseC0242379 associated_with EGFR,lung cancer
13#17#gene195647#58#diseaseC0684249 21130517-0#13#17#gene1956 21130517-0#47#58#diseaseC0684249 associated_with EGFR,lung cancer
13#17#gene195647#58#diseaseC1306460 21130517-0#13#17#gene1956 21130517-0#47#58#diseaseC1306460 associated_with EGFR,lung cancer

tmVarCorpus

Id Subject Object Predicate Lexical cue
T1 710-715 ProteinMutation:p|SUB|L|858|R denotes L858R
T2 1187-1192 ProteinMutation:p|SUB|L|858|R denotes L858R

biored-valid-deepseek-nr-ng

Id Subject Object Predicate Lexical cue
T1 13-17 GeneOrGeneProduct denotes EGFR
T2 47-58 DiseaseOrPhenotypicFeature denotes lung cancer
T3 123-127 GeneOrGeneProduct denotes EGFR
T4 151-155 GeneOrGeneProduct denotes EGFR
T5 219-223 GeneOrGeneProduct denotes EGFR
T6 244-255 DiseaseOrPhenotypicFeature denotes lung cancer
T7 275-279 GeneOrGeneProduct denotes EGFR
T8 512-516 GeneOrGeneProduct denotes EGFR
T9 565-576 DiseaseOrPhenotypicFeature denotes lung cancer
T10 679-683 GeneOrGeneProduct denotes EGFR
T11 684-700 SequenceVariant denotes Exon 19 deletion
T12 710-715 SequenceVariant denotes L858R
T13 1156-1173 SequenceVariant denotes Exon 19 deletions

biored-valid

Id Subject Object Predicate Lexical cue
T1 13-17 GeneOrGeneProduct denotes EGFR
T2 47-58 DiseaseOrPhenotypicFeature denotes lung cancer
T3 59-67 OrganismTaxon denotes patients
T4 117-122 DiseaseOrPhenotypicFeature denotes tumor
T5 123-127 GeneOrGeneProduct denotes EGFR
T6 151-155 GeneOrGeneProduct denotes EGFR
T7 174-178 GeneOrGeneProduct denotes EGFR
T8 219-223 GeneOrGeneProduct denotes EGFR
T9 244-255 DiseaseOrPhenotypicFeature denotes lung cancer
T10 275-279 GeneOrGeneProduct denotes EGFR
T11 327-332 DiseaseOrPhenotypicFeature denotes tumor
T12 512-516 GeneOrGeneProduct denotes EGFR
T13 551-559 OrganismTaxon denotes patients
T14 565-576 DiseaseOrPhenotypicFeature denotes lung cancer
T15 637-645 OrganismTaxon denotes patients
T16 679-683 GeneOrGeneProduct denotes EGFR
T17 705-709 GeneOrGeneProduct denotes EGFR
T18 710-715 SequenceVariant denotes L858R
T19 775-779 GeneOrGeneProduct denotes EGFR
T20 808-813 DiseaseOrPhenotypicFeature denotes tumor
T21 825-829 GeneOrGeneProduct denotes EGFR
T22 859-863 GeneOrGeneProduct denotes EGFR
T23 883-888 DiseaseOrPhenotypicFeature denotes tumor
T24 958-962 GeneOrGeneProduct denotes EGFR
T25 1022-1027 DiseaseOrPhenotypicFeature denotes tumor
T26 1038-1046 OrganismTaxon denotes patients
T27 1151-1155 GeneOrGeneProduct denotes EGFR
T28 1182-1186 GeneOrGeneProduct denotes EGFR
T29 1187-1192 SequenceVariant denotes L858R
T30 1239-1245 DiseaseOrPhenotypicFeature denotes tumors
T31 1311-1316 DiseaseOrPhenotypicFeature denotes tumor
T32 1381-1389 OrganismTaxon denotes patients
T33 1403-1412 ChemicalEntity denotes erlotinib
T34 1467-1471 GeneOrGeneProduct denotes EGFR
T35 1498-1503 DiseaseOrPhenotypicFeature denotes tumor
T36 1535-1543 OrganismTaxon denotes patients
T37 1643-1647 GeneOrGeneProduct denotes EGFR
T38 1747-1751 GeneOrGeneProduct denotes EGFR
T39 1805-1810 DiseaseOrPhenotypicFeature denotes tumor
T40 1811-1815 GeneOrGeneProduct denotes EGFR
T41 1860-1864 GeneOrGeneProduct denotes EGFR
T42 1945-1953 OrganismTaxon denotes patients
T43 1987-1992 DiseaseOrPhenotypicFeature denotes tumor

biored-valid-deepseek-nr-g

Id Subject Object Predicate Lexical cue
T1 13-17 GeneOrGeneProduct denotes EGFR
T2 47-51 DiseaseOrPhenotypicFeature denotes lung
T3 52-58 DiseaseOrPhenotypicFeature denotes cancer
T4 123-127 GeneOrGeneProduct denotes EGFR
T5 174-178 GeneOrGeneProduct denotes EGFR
T6 244-248 DiseaseOrPhenotypicFeature denotes lung
T7 249-255 DiseaseOrPhenotypicFeature denotes cancer
T8 275-279 GeneOrGeneProduct denotes EGFR
T9 512-516 GeneOrGeneProduct denotes EGFR
T10 679-683 GeneOrGeneProduct denotes EGFR
T11 705-709 GeneOrGeneProduct denotes EGFR
T12 775-779 GeneOrGeneProduct denotes EGFR
T13 825-829 GeneOrGeneProduct denotes EGFR
T14 859-863 GeneOrGeneProduct denotes EGFR
T15 958-962 GeneOrGeneProduct denotes EGFR
T16 1151-1155 GeneOrGeneProduct denotes EGFR

biored-valid-deepseek-r-ng

Id Subject Object Predicate Lexical cue
T1 13-17 GeneOrGeneProduct denotes EGFR
T2 38-41 ChemicalEntity denotes DNA
T3 47-58 DiseaseOrPhenotypicFeature denotes lung cancer
T4 117-122 DiseaseOrPhenotypicFeature denotes tumor
T5 684-700 SequenceVariant denotes Exon 19 deletion
T6 710-724 SequenceVariant denotes L858R mutation
T7 1403-1412 ChemicalEntity denotes erlotinib

biored-valid-deepseek-r-g

Id Subject Object Predicate Lexical cue
T1 13-17 GeneOrGeneProduct denotes EGFR
T2 47-58 DiseaseOrPhenotypicFeature denotes lung cancer
T3 117-122 DiseaseOrPhenotypicFeature denotes tumor
T4 151-166 ChemicalEntity denotes EGFR inhibitors
T5 275-279 GeneOrGeneProduct denotes EGFR
T6 327-339 DiseaseOrPhenotypicFeature denotes tumor tissue
T7 512-516 GeneOrGeneProduct denotes EGFR
T8 679-700 SequenceVariant denotes EGFR Exon 19 deletion
T9 705-724 SequenceVariant denotes EGFR L858R mutation
T10 825-836 SequenceVariant denotes EGFR mutant
T11 1014-1027 DiseaseOrPhenotypicFeature denotes primary tumor
T12 1231-1245 DiseaseOrPhenotypicFeature denotes matched tumors
T13 1403-1412 ChemicalEntity denotes erlotinib
T14 1987-2002 DiseaseOrPhenotypicFeature denotes tumor specimens

biored-valid-gemini-nr-ng

Id Subject Object Predicate Lexical cue
T1 13-17 GeneOrGeneProduct denotes EGFR
T2 47-58 DiseaseOrPhenotypicFeature denotes lung cancer
T3 123-127 GeneOrGeneProduct denotes EGFR
T4 151-155 GeneOrGeneProduct denotes EGFR
T5 174-178 GeneOrGeneProduct denotes EGFR
T6 244-255 DiseaseOrPhenotypicFeature denotes lung cancer
T7 512-516 GeneOrGeneProduct denotes EGFR
T8 565-576 DiseaseOrPhenotypicFeature denotes lung cancer
T9 679-683 GeneOrGeneProduct denotes EGFR
T10 684-700 SequenceVariant denotes Exon 19 deletion
T11 710-715 SequenceVariant denotes L858R
T12 775-779 GeneOrGeneProduct denotes EGFR
T13 958-962 GeneOrGeneProduct denotes EGFR
T14 1151-1155 GeneOrGeneProduct denotes EGFR
T15 1156-1173 SequenceVariant denotes Exon 19 deletions
T16 1182-1186 GeneOrGeneProduct denotes EGFR
T17 1403-1412 ChemicalEntity denotes erlotinib

biored-valid-gemini-r-g

Id Subject Object Predicate Lexical cue
T1 13-17 GeneOrGeneProduct denotes EGFR
T2 47-58 DiseaseOrPhenotypicFeature denotes lung cancer
T3 117-122 DiseaseOrPhenotypicFeature denotes tumor
T4 123-127 GeneOrGeneProduct denotes EGFR
T5 151-166 ChemicalEntity denotes EGFR inhibitors
T6 219-223 GeneOrGeneProduct denotes EGFR
T7 244-255 DiseaseOrPhenotypicFeature denotes lung cancer
T8 327-332 DiseaseOrPhenotypicFeature denotes tumor
T9 512-516 GeneOrGeneProduct denotes EGFR
T10 565-576 DiseaseOrPhenotypicFeature denotes lung cancer
T11 679-700 SequenceVariant denotes EGFR Exon 19 deletion
T12 705-724 SequenceVariant denotes EGFR L858R mutation
T13 775-779 GeneOrGeneProduct denotes EGFR
T14 808-813 DiseaseOrPhenotypicFeature denotes tumor
T15 1022-1027 DiseaseOrPhenotypicFeature denotes tumor
T16 1151-1173 SequenceVariant denotes EGFR Exon 19 deletions
T17 1182-1202 SequenceVariant denotes EGFR L858R mutations
T18 1239-1245 DiseaseOrPhenotypicFeature denotes tumors
T19 1403-1412 ChemicalEntity denotes erlotinib
T20 1467-1471 GeneOrGeneProduct denotes EGFR
T21 1498-1503 DiseaseOrPhenotypicFeature denotes tumor

biored-valid-gemini-r-ng

Id Subject Object Predicate Lexical cue
T1 13-27 DiseaseOrPhenotypicFeature denotes EGFR mutations
T2 31-41 ChemicalEntity denotes plasma DNA
T3 47-58 DiseaseOrPhenotypicFeature denotes lung cancer
T4 123-127 GeneOrGeneProduct denotes EGFR
T5 151-166 ChemicalEntity denotes EGFR inhibitors
T6 174-188 DiseaseOrPhenotypicFeature denotes EGFR mutations
T7 244-255 DiseaseOrPhenotypicFeature denotes lung cancer
T8 275-288 DiseaseOrPhenotypicFeature denotes EGFR mutation
T9 512-525 DiseaseOrPhenotypicFeature denotes EGFR mutation
T10 530-545 ChemicalEntity denotes free plasma DNA
T11 586-590 ChemicalEntity denotes DNAs
T12 679-700 SequenceVariant denotes EGFR Exon 19 deletion
T13 705-724 SequenceVariant denotes EGFR L858R mutation
T14 737-743 ChemicalEntity denotes plasma
T15 775-788 DiseaseOrPhenotypicFeature denotes EGFR mutation
T16 808-817 ChemicalEntity denotes tumor DNA
T17 825-836 GeneOrGeneProduct denotes EGFR mutant
T18 958-971 DiseaseOrPhenotypicFeature denotes EGFR mutation
T19 982-992 ChemicalEntity denotes plasma DNA
T20 1093-1099 ChemicalEntity denotes plasma
T21 1118-1128 ChemicalEntity denotes mutant DNA
T22 1151-1173 SequenceVariant denotes EGFR Exon 19 deletions
T23 1182-1202 SequenceVariant denotes EGFR L858R mutations
T24 1276-1286 ChemicalEntity denotes plasma DNA
T25 1403-1412 ChemicalEntity denotes erlotinib
T26 1467-1471 GeneOrGeneProduct denotes EGFR
T27 1643-1657 DiseaseOrPhenotypicFeature denotes EGFR mutations

biored-valid-gpt-nr-ng

Id Subject Object Predicate Lexical cue
T1 13-17 GeneOrGeneProduct denotes EGFR
T2 47-58 DiseaseOrPhenotypicFeature denotes lung cancer
T3 123-127 GeneOrGeneProduct denotes EGFR
T4 151-155 GeneOrGeneProduct denotes EGFR
T5 174-178 GeneOrGeneProduct denotes EGFR
T6 244-255 DiseaseOrPhenotypicFeature denotes lung cancer
T7 512-516 GeneOrGeneProduct denotes EGFR
T8 565-576 DiseaseOrPhenotypicFeature denotes lung cancer
T9 679-700 SequenceVariant denotes EGFR Exon 19 deletion
T10 705-724 SequenceVariant denotes EGFR L858R mutation
T11 775-779 GeneOrGeneProduct denotes EGFR
T12 825-829 GeneOrGeneProduct denotes EGFR
T13 958-962 GeneOrGeneProduct denotes EGFR
T14 1151-1173 SequenceVariant denotes EGFR Exon 19 deletions
T15 1182-1202 SequenceVariant denotes EGFR L858R mutations
T16 1403-1412 ChemicalEntity denotes erlotinib
T17 1467-1471 GeneOrGeneProduct denotes EGFR
T18 1643-1647 GeneOrGeneProduct denotes EGFR
T19 1747-1751 GeneOrGeneProduct denotes EGFR
T20 1811-1815 GeneOrGeneProduct denotes EGFR
T21 1860-1864 GeneOrGeneProduct denotes EGFR

biored-valid-gpt-nr-g

Id Subject Object Predicate Lexical cue
T1 13-17 GeneOrGeneProduct denotes EGFR
T2 47-58 DiseaseOrPhenotypicFeature denotes lung cancer
T3 117-122 DiseaseOrPhenotypicFeature denotes tumor
T4 123-127 GeneOrGeneProduct denotes EGFR
T5 151-166 ChemicalEntity denotes EGFR inhibitors
T6 219-223 GeneOrGeneProduct denotes EGFR
T7 244-255 DiseaseOrPhenotypicFeature denotes lung cancer
T8 275-279 GeneOrGeneProduct denotes EGFR
T9 327-332 DiseaseOrPhenotypicFeature denotes tumor
T10 512-516 GeneOrGeneProduct denotes EGFR
T11 565-576 DiseaseOrPhenotypicFeature denotes lung cancer
T12 679-700 SequenceVariant denotes EGFR Exon 19 deletion
T13 705-724 SequenceVariant denotes EGFR L858R mutation
T14 775-779 GeneOrGeneProduct denotes EGFR
T15 808-813 DiseaseOrPhenotypicFeature denotes tumor
T16 825-829 GeneOrGeneProduct denotes EGFR
T17 958-962 GeneOrGeneProduct denotes EGFR
T18 1022-1027 DiseaseOrPhenotypicFeature denotes tumor
T19 1151-1173 SequenceVariant denotes EGFR Exon 19 deletions
T20 1182-1202 SequenceVariant denotes EGFR L858R mutations
T21 1239-1245 DiseaseOrPhenotypicFeature denotes tumors
T22 1311-1316 DiseaseOrPhenotypicFeature denotes tumor
T23 1403-1412 ChemicalEntity denotes erlotinib
T24 1467-1471 GeneOrGeneProduct denotes EGFR
T25 1498-1503 DiseaseOrPhenotypicFeature denotes tumor
T26 1643-1647 GeneOrGeneProduct denotes EGFR
T27 1747-1751 GeneOrGeneProduct denotes EGFR
T28 1805-1810 DiseaseOrPhenotypicFeature denotes tumor
T29 1811-1815 GeneOrGeneProduct denotes EGFR
T30 1860-1864 GeneOrGeneProduct denotes EGFR
T31 1987-1992 DiseaseOrPhenotypicFeature denotes tumor

biored-valid-gpt-r-ng

Id Subject Object Predicate Lexical cue
T1 13-17 GeneOrGeneProduct denotes EGFR
T2 38-41 ChemicalEntity denotes DNA
T3 47-58 DiseaseOrPhenotypicFeature denotes lung cancer
T4 117-122 DiseaseOrPhenotypicFeature denotes tumor
T5 123-127 GeneOrGeneProduct denotes EGFR
T6 151-155 GeneOrGeneProduct denotes EGFR
T7 174-178 GeneOrGeneProduct denotes EGFR
T8 244-255 DiseaseOrPhenotypicFeature denotes lung cancer
T9 275-279 GeneOrGeneProduct denotes EGFR
T10 327-332 DiseaseOrPhenotypicFeature denotes tumor
T11 512-516 GeneOrGeneProduct denotes EGFR
T12 542-545 ChemicalEntity denotes DNA
T13 565-576 DiseaseOrPhenotypicFeature denotes lung cancer
T14 586-590 ChemicalEntity denotes DNAs
T15 679-683 GeneOrGeneProduct denotes EGFR
T16 705-724 SequenceVariant denotes EGFR L858R mutation
T17 744-747 ChemicalEntity denotes DNA
T18 775-779 GeneOrGeneProduct denotes EGFR
T19 808-813 DiseaseOrPhenotypicFeature denotes tumor
T20 814-817 ChemicalEntity denotes DNA
T21 825-829 GeneOrGeneProduct denotes EGFR
T22 883-888 DiseaseOrPhenotypicFeature denotes tumor
T23 914-930 DiseaseOrPhenotypicFeature denotes overall survival
T24 958-962 GeneOrGeneProduct denotes EGFR
T25 989-992 ChemicalEntity denotes DNA
T26 1022-1027 DiseaseOrPhenotypicFeature denotes tumor
T27 1125-1128 ChemicalEntity denotes DNA
T28 1151-1155 GeneOrGeneProduct denotes EGFR
T29 1182-1202 SequenceVariant denotes EGFR L858R mutations
T30 1239-1245 DiseaseOrPhenotypicFeature denotes tumors
T31 1283-1286 ChemicalEntity denotes DNA
T32 1311-1316 DiseaseOrPhenotypicFeature denotes tumor
T33 1403-1412 ChemicalEntity denotes erlotinib
T34 1414-1430 DiseaseOrPhenotypicFeature denotes overall survival
T35 1467-1471 GeneOrGeneProduct denotes EGFR
T36 1498-1503 DiseaseOrPhenotypicFeature denotes tumor
T37 1568-1571 ChemicalEntity denotes DNA
T38 1643-1647 GeneOrGeneProduct denotes EGFR
T39 1668-1671 ChemicalEntity denotes DNA
T40 1747-1751 GeneOrGeneProduct denotes EGFR
T41 1769-1772 ChemicalEntity denotes DNA
T42 1805-1810 DiseaseOrPhenotypicFeature denotes tumor
T43 1811-1815 GeneOrGeneProduct denotes EGFR
T44 1860-1864 GeneOrGeneProduct denotes EGFR
T45 1987-1992 DiseaseOrPhenotypicFeature denotes tumor

biored-valid-gpt-r-g

Id Subject Object Predicate Lexical cue
T1 13-17 GeneOrGeneProduct denotes EGFR
T2 47-58 DiseaseOrPhenotypicFeature denotes lung cancer
T3 117-122 DiseaseOrPhenotypicFeature denotes tumor
T4 123-127 GeneOrGeneProduct denotes EGFR
T5 151-166 ChemicalEntity denotes EGFR inhibitors
T6 174-188 SequenceVariant denotes EGFR mutations
T7 244-255 DiseaseOrPhenotypicFeature denotes lung cancer
T8 275-279 GeneOrGeneProduct denotes EGFR
T9 327-332 DiseaseOrPhenotypicFeature denotes tumor
T10 512-516 GeneOrGeneProduct denotes EGFR
T11 565-576 DiseaseOrPhenotypicFeature denotes lung cancer
T12 679-683 GeneOrGeneProduct denotes EGFR
T13 705-724 SequenceVariant denotes EGFR L858R mutation
T14 775-779 GeneOrGeneProduct denotes EGFR
T15 808-813 DiseaseOrPhenotypicFeature denotes tumor
T16 825-829 GeneOrGeneProduct denotes EGFR
T17 958-962 GeneOrGeneProduct denotes EGFR
T18 1022-1027 DiseaseOrPhenotypicFeature denotes tumor
T19 1151-1155 GeneOrGeneProduct denotes EGFR
T20 1182-1202 SequenceVariant denotes EGFR L858R mutations
T21 1239-1245 DiseaseOrPhenotypicFeature denotes tumors
T22 1311-1316 DiseaseOrPhenotypicFeature denotes tumor
T23 1403-1412 ChemicalEntity denotes erlotinib
T24 1467-1471 GeneOrGeneProduct denotes EGFR
T25 1498-1503 DiseaseOrPhenotypicFeature denotes tumor
T26 1643-1647 GeneOrGeneProduct denotes EGFR
T27 1747-1751 GeneOrGeneProduct denotes EGFR
T28 1805-1810 DiseaseOrPhenotypicFeature denotes tumor
T29 1811-1815 GeneOrGeneProduct denotes EGFR
T30 1987-1992 DiseaseOrPhenotypicFeature denotes tumor

biored-valid-gemini-nr-g

Id Subject Object Predicate Lexical cue
T1 13-17 GeneOrGeneProduct denotes EGFR
T2 18-27 SequenceVariant denotes mutations
T3 47-58 DiseaseOrPhenotypicFeature denotes lung cancer
T4 117-122 DiseaseOrPhenotypicFeature denotes tumor
T5 123-127 GeneOrGeneProduct denotes EGFR
T6 151-166 ChemicalEntity denotes EGFR inhibitors
T7 179-188 SequenceVariant denotes mutations
T8 219-232 ChemicalEntity denotes EGFR-targeted
T9 244-255 DiseaseOrPhenotypicFeature denotes lung cancer
T10 280-288 SequenceVariant denotes mutation
T11 327-332 DiseaseOrPhenotypicFeature denotes tumor
T12 473-479 SequenceVariant denotes mutant
T13 512-516 GeneOrGeneProduct denotes EGFR
T14 517-526 SequenceVariant denotes mutations
T15 565-576 DiseaseOrPhenotypicFeature denotes lung cancer
T16 679-683 GeneOrGeneProduct denotes EGFR
T17 684-700 SequenceVariant denotes Exon 19 deletion
T18 710-715 SequenceVariant denotes L858R
T19 716-724 SequenceVariant denotes mutation
T20 775-779 GeneOrGeneProduct denotes EGFR
T21 808-813 DiseaseOrPhenotypicFeature denotes tumor
T22 883-888 DiseaseOrPhenotypicFeature denotes tumor
T23 958-962 GeneOrGeneProduct denotes EGFR
T24 963-971 SequenceVariant denotes mutation
T25 1022-1027 DiseaseOrPhenotypicFeature denotes tumor
T26 1151-1155 GeneOrGeneProduct denotes EGFR
T27 1156-1173 SequenceVariant denotes Exon 19 deletions
T28 1182-1186 GeneOrGeneProduct denotes EGFR
T29 1193-1202 SequenceVariant denotes mutations
T30 1239-1244 DiseaseOrPhenotypicFeature denotes tumor
T31 1403-1412 ChemicalEntity denotes erlotinib
T32 1498-1503 DiseaseOrPhenotypicFeature denotes tumor
T33 1860-1873 ChemicalEntity denotes EGFR-targeted

biored-valid-gpt-r-m

Id Subject Object Predicate Lexical cue
T1 13-17 GeneOrGeneProduct denotes EGFR
T2 47-58 DiseaseOrPhenotypicFeature denotes lung cancer
T3 59-67 OrganismTaxon denotes patients
T4 117-122 DiseaseOrPhenotypicFeature denotes tumor
T5 123-127 GeneOrGeneProduct denotes EGFR
T6 151-166 ChemicalEntity denotes EGFR inhibitors
T7 174-178 GeneOrGeneProduct denotes EGFR
T8 244-255 DiseaseOrPhenotypicFeature denotes lung cancer
T9 275-279 GeneOrGeneProduct denotes EGFR
T10 512-516 GeneOrGeneProduct denotes EGFR
T11 551-559 OrganismTaxon denotes patients
T12 565-576 DiseaseOrPhenotypicFeature denotes lung cancer
T13 637-645 OrganismTaxon denotes patients
T14 679-683 GeneOrGeneProduct denotes EGFR
T15 684-700 SequenceVariant denotes Exon 19 deletion
T16 710-715 SequenceVariant denotes L858R
T17 775-779 GeneOrGeneProduct denotes EGFR
T18 808-813 DiseaseOrPhenotypicFeature denotes tumor
T19 825-829 GeneOrGeneProduct denotes EGFR
T20 883-888 DiseaseOrPhenotypicFeature denotes tumor
T21 958-962 GeneOrGeneProduct denotes EGFR
T22 1022-1027 DiseaseOrPhenotypicFeature denotes tumor
T23 1038-1046 OrganismTaxon denotes patients
T24 1151-1155 GeneOrGeneProduct denotes EGFR
T25 1156-1173 SequenceVariant denotes Exon 19 deletions
T26 1187-1192 SequenceVariant denotes L858R
T27 1239-1245 DiseaseOrPhenotypicFeature denotes tumors
T28 1311-1316 DiseaseOrPhenotypicFeature denotes tumor
T29 1381-1389 OrganismTaxon denotes patients
T30 1403-1412 ChemicalEntity denotes erlotinib
T31 1467-1471 GeneOrGeneProduct denotes EGFR
T32 1498-1503 DiseaseOrPhenotypicFeature denotes tumor
T33 1535-1543 OrganismTaxon denotes patients
T34 1643-1647 GeneOrGeneProduct denotes EGFR
T35 1747-1751 GeneOrGeneProduct denotes EGFR
T36 1805-1810 DiseaseOrPhenotypicFeature denotes tumor
T37 1811-1815 GeneOrGeneProduct denotes EGFR
T38 1945-1953 OrganismTaxon denotes patients
T39 1987-1992 DiseaseOrPhenotypicFeature denotes tumor

biored-valid-gemini-r-m

Id Subject Object Predicate Lexical cue
T1 13-17 GeneOrGeneProduct denotes EGFR
T2 47-58 DiseaseOrPhenotypicFeature denotes lung cancer
T3 59-67 OrganismTaxon denotes patients
T4 117-122 DiseaseOrPhenotypicFeature denotes tumor
T5 123-127 GeneOrGeneProduct denotes EGFR
T6 151-166 ChemicalEntity denotes EGFR inhibitors
T7 174-178 GeneOrGeneProduct denotes EGFR
T8 219-223 GeneOrGeneProduct denotes EGFR
T9 244-255 DiseaseOrPhenotypicFeature denotes lung cancer
T10 327-332 DiseaseOrPhenotypicFeature denotes tumor
T11 512-516 GeneOrGeneProduct denotes EGFR
T12 551-559 OrganismTaxon denotes patients
T13 565-576 DiseaseOrPhenotypicFeature denotes lung cancer
T14 679-700 SequenceVariant denotes EGFR Exon 19 deletion
T15 705-715 SequenceVariant denotes EGFR L858R
T16 775-779 GeneOrGeneProduct denotes EGFR
T17 808-813 DiseaseOrPhenotypicFeature denotes tumor
T18 859-863 GeneOrGeneProduct denotes EGFR
T19 883-888 DiseaseOrPhenotypicFeature denotes tumor
T20 1038-1046 OrganismTaxon denotes patients
T21 1151-1173 SequenceVariant denotes EGFR Exon 19 deletions
T22 1182-1192 SequenceVariant denotes EGFR L858R
T23 1239-1245 DiseaseOrPhenotypicFeature denotes tumors
T24 1311-1316 DiseaseOrPhenotypicFeature denotes tumor
T25 1381-1389 OrganismTaxon denotes patients
T26 1403-1412 ChemicalEntity denotes erlotinib
T27 1467-1471 GeneOrGeneProduct denotes EGFR
T28 1643-1647 GeneOrGeneProduct denotes EGFR
T29 1747-1751 GeneOrGeneProduct denotes EGFR
T30 1805-1810 DiseaseOrPhenotypicFeature denotes tumor
T31 1945-1953 OrganismTaxon denotes patients

biored-valid-deepseek-r-m

Id Subject Object Predicate Lexical cue
T1 13-17 GeneOrGeneProduct denotes EGFR
T2 47-58 DiseaseOrPhenotypicFeature denotes lung cancer
T3 117-122 DiseaseOrPhenotypicFeature denotes tumor
T4 151-166 ChemicalEntity denotes EGFR inhibitors
T5 679-700 SequenceVariant denotes EGFR Exon 19 deletion
T6 705-724 SequenceVariant denotes EGFR L858R mutation
T7 1403-1412 ChemicalEntity denotes erlotinib